Mapel DW - Search Results

1

Predicting risk of airflow obstruction in primary care: Validation of the lung function questionnaire (LFQ).

Hanania NA, Mannino DM, Yawn BP, Mapel DW, Martinez FJ, Donohue JF, Kosinski M, Rendas-Baum R, Mintz M, Samuels S, Jhingran P, Dalal AA. Hanania NA, et al. Among authors: mapel dw. Respir Med. 2010 Aug;104(8):1160-70. doi: 10.1016/j.rmed.2010.02.009. Epub 2010 Mar 11. Respir Med. 2010. PMID: 20226647 Free article.

2

The health impact of undiagnosed airflow obstruction in a national sample of United States adults.

Coultas DB, Mapel D, Gagnon R, Lydick E. Coultas DB, et al. Am J Respir Crit Care Med. 2001 Aug 1;164(3):372-7. doi: 10.1164/ajrccm.164.3.2004029. Am J Respir Crit Care Med. 2001. PMID: 11500335

3

Predicting the costs of managing patients with chronic obstructive pulmonary disease.

Mapel DW, McMillan GP, Frost FJ, Hurley JS, Picchi MA, Lydick E, Spencer MD. Mapel DW, et al. Respir Med. 2005 Oct;99(10):1325-33. doi: 10.1016/j.rmed.2005.03.001. Epub 2005 Apr 22. Respir Med. 2005. PMID: 16140232 Free article. Clinical Trial.

4

The natural history of chronic obstructive pulmonary disease.

Mannino DM, Watt G, Hole D, Gillis C, Hart C, McConnachie A, Davey Smith G, Upton M, Hawthorne V, Sin DD, Man SF, Van Eeden S, Mapel DW, Vestbo J. Mannino DM, et al. Among authors: mapel dw. Eur Respir J. 2006 Mar;27(3):627-43. doi: 10.1183/09031936.06.00024605. Eur Respir J. 2006. PMID: 16507865 Free article. Review.

5

Burden of concomitant asthma and COPD in a Medicaid population.

Shaya FT, Dongyi D, Akazawa MO, Blanchette CM, Wang J, Mapel DW, Dalal A, Scharf SM. Shaya FT, et al. Among authors: mapel dw. Chest. 2008 Jul;134(1):14-9. doi: 10.1378/chest.07-2317. Epub 2008 Mar 13. Chest. 2008. PMID: 18339789

6

COPD as a lung disease with systemic consequences--clinical impact, mechanisms, and potential for early intervention.

Decramer M, Rennard S, Troosters T, Mapel DW, Giardino N, Mannino D, Wouters E, Sethi S, Cooper CB. Decramer M, et al. Among authors: mapel dw. COPD. 2008 Aug;5(4):235-56. doi: 10.1080/15412550802237531. COPD. 2008. PMID: 18671149 Review.

7

Cost-effectiveness of fluticasone propionate/salmeterol (500/50 microg) in the treatment of COPD.

Earnshaw SR, Wilson MR, Dalal AA, Chambers MG, Jhingran P, Stanford R, Mapel DW. Earnshaw SR, et al. Among authors: mapel dw. Respir Med. 2009 Jan;103(1):12-21. doi: 10.1016/j.rmed.2008.10.005. Epub 2008 Nov 17. Respir Med. 2009. PMID: 19010652 Free article.

8

The role of combination inhaled corticosteroid/long-acting beta-agonist therapy in COPD management.

Mapel DW, Hurley JS, Dalal AA, Blanchette CM. Mapel DW, et al. Prim Care Respir J. 2010 Jun;19(2):93-103. doi: 10.4104/pcrj.2010.00020. Prim Care Respir J. 2010. PMID: 20339822 Free PMC article. Review.

9

Development of the Lung Function Questionnaire (LFQ) to identify airflow obstruction.

Yawn BP, Mapel DW, Mannino DM, Martinez FJ, Donohue JF, Hanania NA, Kosinski M, Rendas-Baum R, Mintz M, Samuels S, Dalal AA; Lung Function Questionnaire Working Group. Yawn BP, et al. Among authors: mapel dw. Int J Chron Obstruct Pulmon Dis. 2010 Feb 18;5:1-10. Int J Chron Obstruct Pulmon Dis. 2010. PMID: 20368906 Free PMC article.

10

Adherence to controller therapy for chronic obstructive pulmonary disease: a review.

Charles MS, Blanchette CM, Silver H, Lavallee D, Dalal AA, Mapel D. Charles MS, et al. Curr Med Res Opin. 2010 Oct;26(10):2421-9. doi: 10.1185/03007995.2010.516284. Curr Med Res Opin. 2010. PMID: 20815661 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

82 results

Search Page